Myelodysplasia (MDS) is mostly characterized by a normal or increased number of normoblasts in the bone marrow and an impaired in vitro colony formation. In the present study we analyzed whether this might be due to a disconnection between proliferation and differentiation. CD34 + cells during the first days of the cell suspension culture phase. These results suggest that a defect in the proliferative response is most pronouncedly expressed in MDS whereas a subpopulation of cells retain the capacity to differentiate between transition to a terminated stage.
Introduction
Myelodysplasia is a pre-leukemic disorder affecting the erythroid, myeloid, and megakaryocytic lineage. The disorder is classified according to the FAB classification and includes refractory anemia (RA), refractory anemia with ring sideroblasts (RARS) and refractory anemia with excess of blasts (RAEB). In particular in RA and RAEB, a differentiation block is observed in the erythroid lineage. 1, 2 In vitro culture assays with CD34
+ sorted bone marrow cells of MDS patients have shown a reduced to absent number of BFU-E and CFU-E in response to erythropoietin (Epo) or Epo plus mast cell growth factor (MGF) and interleukin-3 (IL-3) stimulation. [3] [4] [5] In addition, a differentiation defect can be seen at the level of BFU-E precursors. 6 In spite of the strong impairment in the proliferative capacity of erythroid progenitors, bone marrow
Correspondence: E Vellenga, University Hospital Groningen, Department of Hematology, Postbus 30.001, 9700 RB Groningen, The Netherlands; Fax: 31 50 3614862 Received 9 July 1997; accepted 25 February 1998 morphology of MDS patients frequently demonstrates a normal to slightly increased number of normoblasts at different stages of differentiation. These findings suggest that the erythroid progenitor cell has the persistent potential to differentiate to a certain degree along the erythroid lineage in response to growth factor stimulation whereas it has limited capacity to proliferate. To study whether such a disconnection between proliferation and differentiation can be observed in MDS, in vitro clonogenic and suspension culture assays with CD34 + /CD36 − sorted bone marrow cells of MDS patients were performed in the presence of Epo and MGF. The results demonstrate that CD34
− sorted cells are strongly impaired in proliferative response in the presence of Epo and MGF, whereas the cells retain the capacity to differentiate.
Materials and methods

Patients
Bone marrow cells were obtained from 18 patients with MDS, after informed consent. The patients were classified according to FAB criteria as RA, RARS, RAEB and RAEB-T. 7 In addition, bone marrow cells from healthy controls were obtained after informed consent.
Culture conditions
Mononuclear cells (MNC) were isolated by density gradient centrifugation using Lymphoprep (Nycomed, Oslo, Norway). The MNC were incubated overnight in RPMI 1640 culture medium (BioWhittaker, Walkersville, MD, USA) and 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA) in a plastic culture disk at 37°C in 5% CO 2 to allow adherence. Nonadherent cells were incubated with a phycoerythrin-labeled anti-CD34 monoclonal antibody (MoAb) HPCA-2; Becton Dickinson, San Jose, CA, USA) and a fluorescein isothiocyanate-labeled anti-CD36 MoAb (CD36, IQP, Groningen, The Netherlands). After washing, the cells were sorted with a fluorescence-activated cell sorter (FACStar; Becton Dickinson) in a CD34
− subpopulation. The purity of the sorted cell fraction was greater than 95% as tested by re-analysis.
BFU-E assays were performed in duplicate according to Iscove as previously described.
8 CD34
) sorted cell fractions were added to 1 ml of culture medium consisting of 1.1% methylcellulose (Fluka Chemie, Buchs, Switzerland), 20% heat-inactivated FBS, 10% deionized bovine serum albumin (BSA) (Cohn Fraction V; Sigma Chemical, St Louis, MO, USA), 0.1% ␣-thioglycerol (Sigma), and Iscove's medium (IMDM; Flow Laboratories, Rockville, MD, USA) in the presence of Epo (1 U/ml; Amgen, Oakland, CA, USA) and MGF (1 U/ml, specific activity 1 × 10 5 U/mg; Immunex, Seattle, WA, USA). All cultures were performed in 24-well culture plates (Costar, Cambridge, MA, USA), and kept at 37°C in a 5% CO 2 air humidified atmosphere. BFU-E were scored on day 14 according to their characteristic morphology by using an inverted microscope.
Suspension cultures CD34
+
/CD36
− (1 × 10 4 ) were incubated in duplicates in 100 l Iscove's medium (Gibco, Gaithersburg, MD, USA) with 10% FBS with Epo (1 U/ml) plus MGF (1 U/ml). After 7 days the cells were re-analyzed regarding the cell number, cell morphology (including normoblasts at different stages of differentiation), and the expression of CD34 and CD36 and Glycophorin A (GpA, Clone Ic159; Dako, Glostrup, Denmark). For the FACS analysis the cells were resuspended in RPMI 1640 and washed once followed by staining with the different monoclonal antibodies. The cell pellet was resuspended in 100 l RPMI 1640 and analyzed using the FACSstar flow cytometer. Generally, data of 10 4 cells were obtained but in cases with impaired proliferation a minimum of 2500 cells was analyzed. Data analysis was performed with FACSstar lysis software. The Naegeotte hemocytometer was used to count the cell number after 7 days of culture. 9 In addition, the washed cells were used for the in vitro CFU-E colony assay by culturing the cells in the presence of Epo (1 U/ml) as described above. After 7 days the CFU-E were scored according to their characteristic morphology by using an inverted microscope.
Annexin-V assay
The CD34
+ /CD36 − sorted cells were collected directly after sorting (day 0) or incubated in a microtiterplate in the presence of 100 l Iscove's medium with 10% FBS with Epo (1 U/ml) plus MGF (1 U/ml). After the incubation period, cells were stained for 15 min at room temperature with FITClabeled Annexin-V (Bender Med System, Vienna, Austria) at a final concentration of 3 g/ml. Cells were washed once, resuspended in 50 l RPMI 1640 and put on coverslip slides. The number of positive cells was determined by using a Leitz Orthoplan (Wetzlar, Germany) microscope. A minimum number of 100 cells was counted in duplicate and scored as apoptotic cells if the cells showed membrane fluorescence. In conjunction with this assay, viability of cells was analyzed by means of trypan blue staining.
Statistical analysis
Statistical analysis was performed on data of the cell suspension assay by using the Student's t-test. Statistical significance of the data was set at P Ͻ 0.05.
Results
Patients' characteristics
Bone marrow cells were collected from 18 patients with MDS. Bone marrow cytology categorised the patients as RA (n = 8), RARS (n = 5) and RAEB or RAEB-T (n = 5). The percentage of erythroid cells in the bone marrow varied for the different cases between 17 and 71% (38 ± 13%). However, distinct signs of dyserythropoiesis were observed in all cases. Transfusion dependency was observed in 30% of the cases with RA/RARS and in 80% of the cases with RAEB/RAEB-T.
The effects of Epo plus MGF on CD34 progenitors
First, the number of erythroid progenitor cells was determined in the clonogenic assay. CD34
− sorted bone marrow cells of MDS patients were cultured in the colony assay in the presence of Epo and MGF. In 62% of the cases with RA and RARS the sorted CD34
− cells contained low numbers of BFU-E (75 ± 88 BFU-E/10 4 CD34 + /CD36 − cells). In most cases (77%) with BFU-E, CFU-E were also demonstrated from the CD34
− sorted cell population after the suspension culture phase (Table 1 ). In contrast, in most of the cases (80%) with RAEB or RAEB-T no BFU-E or CFU-E colony formation was demonstrated.
Secondly, we questioned whether the degree of impairment in the erythroid colony formation was associated with disturbed proliferation and differentiation in the suspension culture assay. For erythroid differentiation CD36 and GpA were used. The combination of Epo and MGF triggers CD34
− sorted cells selectively along the erythroid lineage without differentiation along the myeloid and monocytic lineage. 8 Normal bone marrow CD34
+ after 7 days culture with Epo plus MGF. 7 Subsequently, CD34 + /CD36 − sorted cells of MDS patients were cultured in suspension in the presence of Epo and MGF. After 7 days the total cell number was counted in combination with morphology and FACS analysis. In all cases with Ͼ10 BFU-E, the number of CD34
− cells expanded to a certain degree although great variability existed (8.9 ± 6.5-fold expansion). FACS analysis after 7 days of culture demonstrated that in five out of eight cases the cells became CD34 −
/CD36
+ including patient 7 who had Ͼ1000 CFU-E/10 4 CD34 − /CD36 + cells. The erythroid origin was confirmed by Glycophorin-A expression (Table 1) . However, in two cases (Nos 1 and 15) a partial differentiation was noticed. In these cases a high percentage of CD34
− persisted. Cell morphology after 7 days of culture demonstrated in all cases extensive erythroid differentiation reflected by the presence of erythroblasts and normoblasts at different stages of differentiation. In the 10 cases with less than 10 BFU-E, a significant difference was observed in the proliferative response (P Ͻ 0.01) compared to the cases with more than 10 BFU-E. In three cases a 1.9-fold or more expansion of the CD34
− cells was demonstrated whereas the additional cases demonstrated a decline in the cell number in time (0.5 ± 0.2-fold expansion). The latter was especially so in cases with RAEB/RAEB-T. FACS analysis after 7 days of culture demonstrated a variable pattern (Table 1; Figure 1) . In four cases a high percentage of CD34 + /CD36 − cells (Ͼ50%) was observed which was frequently associated with a low percentage of CD34 − /CD36 + cells. In the additional cases a mixture of CD34 +
− and CD34 − /CD36 + cells was observed indicating that a subset of patients demonstrated a partial differentiation along the erythroid lineage. Cell morphology after 7 days of culture demonstrated in five out of nine cases minimal (Ͻ10% erythroblasts and normoblasts) to limited erythroid differentiation (10-50% erythroblasts and normoblasts) and in 44% of the cases extensive differentiation along the erythroid lineage (Ͼ50% erythroblasts and normoblasts). The lack of proliferation and/or differentiation was not related to the Epo dose used since higher concentration of Epo (10 U/ml) in the assays gave similar results (data not shown). To exclude the Normal bone Ͼ1000 159 ± 17 127 ± 40 4.8 ± 5.6 4 ± 6 7 9± 9.6 80 ± 8 E marrow (X ± sd/n = 4)
CFU-E and BFU-E were cultured in in vitro clonogenic assay in the presence of Epo and MGF. Table 1 .
− cells in MDS SJL Brada et al possibility that the erythroid cells belonged to a clone of normal cells, iron staining was performed in two cases with RARS. In all the studied cases a high number of ring-sideroblasts was observed.
Finally we analyzed whether the impaired expansion of CD34
− cells in response to Epo and MGF stimulation was due to an enhanced tendency of apoptosis. CD34
− sorted cells from cases with a strong impairment in the proliferation (Nos 11, 14 and 16), with a moderate proliferation (Nos 7, 9 and 12) and normal bone marrow (n = 3) were studied with regard to the binding of Annexin-V at days 0 and 2-3 of the suspension culture phase in the presence of Epo plus MGF. In addition, the viability of the cells was tested at the same time point by means of trypan blue exclusion assay. In all cases tested more than 95% of the cells were viable. At day 0 the percentage of Annexin-V positive was in all cases Ͻ1%. After 2-3 days of culture, the percentage of Annexin-Vpositive cells on normal CD34
+ bone marrow cells was Ͻ10% (n = 3); the percentage of Annexin-V-positive cells varied between 8 and 17% in cases 7, 9 and 12 while the percentage of Annexin-V-positive cells varied between 17 and 35% in cases 11, 14 and 16 with an impaired proliferation.
Discussion
Bone marrow examination in MDS patients frequently demonstrates a normal or increased number of erythroblasts at different stages of differentiation. These results are in contrast to findings obtained with in vitro culture assays demonstrating an impaired erythroid colony formation in response to Epo and additional growth factor stimulation. 2, 10 The data suggest an uncoupling between the proliferative and differentiating capacity of erythroid progenitor cells. To study this aspect in more detail CD34
− sorted cells of MDS patients were cultured under different experimental conditions. The results demonstrate that different response patterns can be recognized. A minority of the patients shows a pattern comparable to normal erythroid progenitor cells. 8 Erythroid colony formation was observed in response to Epo plus MGF stimulation whereas the CD34
+ after 7 days in the suspension culture assay. In the majority of the MDS patients an impaired erythroid colony formation was observed in the presence of Epo plus MGF in conjunction with a decline in the cell number in the cell suspension assay. The decline in cell number was not in all cases associated with a lack of differentiation. In different cases the CD34 + cells demonstrated a persistent capacity to differentiate reflected by the appearance of CD34
+ cells. However, the degree of differentiation varied between a transition to a terminal differentiated stage. Moreover, it appeared that the antigen expression on erythroid cells was not in all cases in parallel with the morphology. The discrepancy is not specific for MDS but has also been observed in acute myeloid leukemia where a discordant antigen expression is frequently noticed as a result of the malignant character of the disorder. 11 The data suggest that the most prominent defect in MDS is a lack in the proliferative capacity of CD34
− cells. The cause is unknown but might be related to a defect in the intracellular signaling. An impaired DNA binding of STAT-5 in response to Epo activation has been demonstrated in MDS. 12 Transfection studies with different mutated Epo receptor constructs have shown that the inability of Epo to induce STAT-5 binding is associated with an impaired proliferation. 13 However, the impaired proliferation in the experiments was especially observed at a low dose of Epo while a higher Epo dose could partially correct the proliferative defect in conjunction with a slight induction of STAT-5 DNA binding activity. In MDS, however, an additional defect has to be present since no defects in the Epo receptor complex have so far been demonstrated. 12 Furthermore, it is conceivable that an aberrant expression of Evi-I might interfere in these interactions.
14 Evi-I is frequently expressed in MDS, also in cases without a chromosomal abnormality t (3,3)(q21;q26) . 3, 15 Evi-I interferes with the function of GATA-1 proteins resulting in an impaired proliferation of the erythroid progenitor cells.
14 Despite the lack of proliferation in several cases, differentiation along the erythroid lineage was frequently observed as tested with cell morphology and FACS analysis. The observed uncoupling between proliferation and differentiation is not specific for MDS but has also been observed in cell lines. Fairbairn et al 16 demonstrated that FDPC-1 cells transfected with bcl-2 did have the capacity to differentiate in serum-free medium in the absence of cell division.
Recently, it was shown that an increased percentage of apoptotic cells can be observed in the bone marrow of MDS patients. 17 The cause is not elucidated but some findings suggest that an increased expression of Fas and Fas ligand might be involved as well as an augmented activity of the interleukin-1 converting enzyme (ICE). 18, 19 In addition, an altered balance between c-Myc and Bcl-2 oncoproteins has been demonstrated. 20 It is conceivable that the aberrant activities of these factors are contributory especially since an inhibitor of ICE activity could partially block the apoptotic process. 19 In the present study we also observed an augmented tendency of apoptosis of CD34 + /CD36 − cells especially in cases with an impaired proliferative response to growth factor stimulation. However, the enhanced binding of Annexin-V was especially observed during the cell culture phase. These data support the notion that the intracellular signaling pathway in response to Epo stimulation is insufficiently activated. This might indicate that Epo is unable to act as a survival factor in these cases.
Finally, the results demonstrate that the most pronounced defects were observed in RAEB or RAEB-T. In these cases a defect in proliferation and differentiation was observed in the erythroid lineage suggesting that the ongoing transformation is associated with an extension of cellular defects. Whether such a finding has prognostic value at presentation requires study in larger number of patients.
